University of Oxford
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Acarbose Cardiovascular Evaluation Trial
- Conditions
- Type 2 Diabetes Mellitus (T2DM)Coronary Heart DiseaseAcute Coronary SyndromeImpaired Glucose Tolerance
- Interventions
- Drug: Matching Placebo
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 6526
- Registration Number
- NCT00829660
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Beijing Chuiyangliu Hospital, Beijing, Beijing, China
🇨🇳China Meitan General Hospital, Beijing, Beijing, China
A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV
- Conditions
- Tuberculosis
- Interventions
- Biological: MVA85A
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 24
- Registration Number
- NCT00731471
- Locations
- 🇸🇳
Centre Hospitalier Le Dantec, Dakar, Senegal
Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria
- Conditions
- Severe Falciparum Malaria
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2015-01-22
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 80
- Registration Number
- NCT00692627
- Locations
- 🇧🇩
Chittagong Medical College Hospital, Chittagong, Bangladesh
A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
- Conditions
- Uncomplicated Falciparum MalariaVivax Malaria
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2018-05-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 1086
- Registration Number
- NCT00682578
- Locations
- 🇦🇫
Provincial Malaria Control Centers (MRC), Takhar, Afghanistan
A Study of MVA85A in Healthy Children and Infants
- Conditions
- Tuberculosis
- Interventions
- Biological: MVA85ABiological: Prevenar
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2010-02-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 168
- Registration Number
- NCT00679159
- Locations
- 🇿🇦
University Cape Town, Worcester, Western Cape, South Africa
A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A
- Conditions
- Tuberculosis
- Interventions
- Biological: FP85ABiological: MVA85A
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2010-02-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 31
- Registration Number
- NCT00653770
- Locations
- 🇬🇧
CCVTM, University of Oxford, Oxford, United Kingdom
Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine
- Conditions
- TB
- Interventions
- Biological: BCG
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2008-04-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 11
- Registration Number
- NCT00654316
- Locations
- 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination
- Conditions
- Tuberculosis
- Interventions
- Biological: BCG
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2010-07-01
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT00653627
- Locations
- 🇬🇧
CCVTM, University of Oxford, Oxford, United Kingdom
A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years
- Conditions
- Transient Hypothyroxinemia
- Interventions
- First Posted Date
- 2008-03-18
- Last Posted Date
- 2015-05-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 1275
- Registration Number
- NCT00638092
- Locations
- 🇬🇧
Ninewells Hospital and Medical School, Dundee, Tayside, United Kingdom
🇬🇧Royal Maternity Hospital, Belfast, United Kingdom
🇬🇧Heartlands Hospital, Birmingham, United Kingdom
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2008-06-04
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 750
- Registration Number
- NCT00579956
- Locations
- 🇹🇭
Sappasithiprasong Hospital, Ubonratchathani, Ubon, Thailand
🇹🇭Udon Thani General Hospital, Udon Thani, Thailand